Ülke: ABD
Dil: İngilizce
Kaynak: NLM (National Library of Medicine)
PROPRANOLOL HYDROCHLORIDE (UNII: F8A3652H1V) (PROPRANOLOL - UNII:9Y8NXQ24VQ)
Bryant Ranch Prepack
ORAL
PRESCRIPTION DRUG
Propranolol Hydrochloride Tablets USP are indicated in the management of hypertension. They may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol Hydrochloride Tablets USP are not indicated in the management of hypertensive emergencies. Propranolol Hydrochloride Tablets USP are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Propranolol Hydrochloride Tablets USP are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Propranolol Hydrochloride Tablets USP are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. Propranolol Hydrochloride Tablets USP are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not in
Product: 71335-0405 NDC: 71335-0405-3 90 TABLET in a BOTTLE NDC: 71335-0405-4 60 TABLET in a BOTTLE NDC: 71335-0405-1 30 TABLET in a BOTTLE NDC: 71335-0405-2 100 TABLET in a BOTTLE Product: 71335-0463 NDC: 71335-0463-2 60 TABLET in a BOTTLE NDC: 71335-0463-3 100 TABLET in a BOTTLE NDC: 71335-0463-4 90 TABLET in a BOTTLE NDC: 71335-0463-1 30 TABLET in a BOTTLE
Abbreviated New Drug Application
PROPRANOLOL HYDROCHLORIDE- PROPRANOLOL HYDROCHLORIDE TABLET BRYANT RANCH PREPACK ---------- PROPRANOLOL HYDROCHLORIDE TABLETS USP 467 468 469 470 471 RX ONLY DESCRIPTION Propranolol hydrochloride, USP is a synthetic beta-adrenergic receptor blocking agent chemically described as 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-, hydrochloride,(±)-. Its structural formula is: C H NO •HCl M.W. 295.80 Propranolol hydrochloride, USP is a stable, white, crystalline solid which is readily soluble in water and in ethanol. Propranolol Hydrochloride Tablets USP are available as tablets for oral administration containing either 10 mg, 20 mg, 40 mg, 60 mg, or 80 mg of propranolol hydrochloride, USP. Propranolol Hydrochloride Tablets USP also contain lactose anhydrous, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate. Color additives include FD&C Yellow no. 6 aluminum lake (10 mg and 80 mg), D&C Yellow no. 10 aluminum lake (10 mg, 40 mg, and 80 mg), FD&C Blue no. 1 aluminum lake (20 mg and 40 mg) and FD&C Red no. 40 aluminum lake (60 mg). CLINICAL PHARMACOLOGY GENERAL Propranolol is a nonselective beta-adrenergic receptor blocking agent possessing no other autonomic nervous system activity. It specifically competes with beta-adrenergic receptor agonist agents for available receptor sites. When access to beta-receptor sites is blocked by propranolol, the chronotropic, inotropic, and vasodilator responses to beta-adrenergic stimulation are decreased proportionately. At dosages greater than required for beta-blockade, propranolol also exerts a quinidine-like or anesthetic-like membrane action, which affects the cardiac action potential. The significance of the membrane action in the treatment of arrhythmias is uncertain. 16 21 2 MECHANISM OF ACTION The mechanism of the antihypertensive effect of propranolol has not been established. Factors that may contribute to the antihypertensive action include: (1) decreased cardiac output, (2) inhibition of renin release by the kidneys, and (3) dimi Belgenin tamamını okuyun